![](/img/cover-not-exists.png)
Bortezomib-Cyclophosphamide-Dexamethasone (VCD) versus Bortezomib-Thalidomide-Dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis
Leiba, Merav, Kedmi, Meirav, Duek, Adrian, Freidman, Tzachi, Weiss, Mia, Leiba, Ronit, Nagler, Arnon, Avigdor, AbrahamVolume:
166
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12946
Date:
September, 2014
File:
PDF, 521 KB
english, 2014